Top Markets
Coin of the day
BIONET Corp. BIONET Corp.

BIONET Corp.

1784
Rang in Aktien #21907
Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a... Established in 1989 and headquartered in Taipei City, Taiwan, BIONET Corp. is a global leader in umbilical cord blood preservation, serving clients across Taiwan and internationally. The company provides a comprehensive suite of stem cell banking services, encompassing the storage of general stem cells, mesenchymal stem cells, dental stem cells, adipose stem cells, and peripheral blood stem cells combined with immune cells. Beyond its core stem cell preservation, BIONET also conducts genetic testing services. Its product offerings further extend to anti-aging solutions leveraging stem cell technology, alongside its unique ANIKINE series. Additionally, the company is a pioneer in offering Exosome, an innovative cell-free therapeutic approach.
Aktienkurs
$1.95
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$98.22M
Veränderung (1 Tag)
-0.16%
Veränderung (1 Jahr)
-22.25%
Land
TW
Handel BIONET Corp. (1784)

Kategorie

Dividendenrendite-Verlauf für BIONET Corp. (1784)
Dividendenrendite (TTM) von BIONET Corp. (Aktienkürzel: 1784) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für BIONET Corp. (1784) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber
Unternehmen Dividendenrendite Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH